Neurosom™ has announced the imminent close of an oversubscribed bridge round, a strong validation of our mission to transform deep and REM sleep into a therapeutic pathway for long-term brain health.
Previous
Previous
Neurosom scientist and collaborators at Mount Sinai published a new paper.
Next
Next